Position in ERAS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$78,880,508
+$66,487,634 QoQ
Shares Held
4,875,186
+46.3% QoQ
Ownership
1.57%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
18 quarters on record
Voting authority
Sole 97.96329822082686.ToString("F0")%
Shared 0.5856391940738261.ToString("F0")%
None 1.4510625850993173.ToString("F0")%
Common Shares in ERAS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GOLDMAN SACHS GROUP INC holds $10,294,260,512 across 365 Biotechnology names. ERAS ranks #32 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,417,875 | $1,079,677,898 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,300,558 | $1,004,863,129 | |
| 3 | MRNA |
Moderna, Inc.
|
6,603,697 | $335,467,805 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
11,111,591 | $307,791,069 | |
| 5 | PRAX |
Praxis Precision Medicines, Inc.
|
710,734 | $228,991,385 | |
| 6 | INCY |
Incyte Corp
|
2,351,221 | $221,296,919 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
2,185,500 | $212,539,874 | |
| 8 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,965,432 | $170,933,620 |
All Filings in ERAS
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $78,880,508 | 4,875,186 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $12,392,874 | 3,331,418 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $5,487,468 | 2,517,188 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $2,311,207 | 1,819,849 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $2,652,670 | 1,936,257 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $7,032,090 | 2,801,630 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $8,818,871 | 3,230,356 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $5,174,620 | 2,192,636 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $3,258,952 | 1,582,016 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $2,762,698 | 1,297,042 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $1,307,782 | 663,850 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $1,737,425 | 629,502 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $2,192,480 | 728,399 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $1,974,432 | 458,105 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $10,963,812 | 1,405,617 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $2,458,503 | 441,383 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $2,964,763 | 344,740 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,094,276 | 70,236 | Shares | Defined | 2022-02-17 | |
| No filing history on record for this holder in this stock. | ||||||